No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
RADCQ250117P2500
- 1.95
- 0.000.00%
15min DelayClose Oct 11 12:16 ET
0.00High0.00Low
1.95Open1.95Pre Close0 Volume1 Open Interest2.50Strike Price0.00Turnover0.00%IV-1000.00%PremiumJan 17, 2025Expiry Date2.45Intrinsic Value100Multiplier178DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.02Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Express News | Advisory: Alert on Rite Aid Data Breach Issued off Software Development Firm Avatier's Press Release Is Being Withdrawn
Express News | Rite Aid Discloses Data Breach Affecting 2.2 Million Individuals: Avatier's Patent-Pending Technology Offers a Preventive Solution
Express News | Rite Aid - Our Stores and Pharmacies Are Fully Operational, and Our Customers Can Expect Minimal Disruption to Services
Express News | Rite Aid - the Global Cyber Outage Has Had Minimal Impact on Some of Our Store Systems, and We Are Resolving Any Minor Impacts
Rite Aid Reports Breach Of Certain Consumer Data In Recent Hack
Rite Aid Hit by Cyberattack After Third Party Impersonates Worker at Bankrupt Drugstore Chain
Comments
Rite Aid's CEO, Jeffrey S. Stein, believes the MedImpact transaction optimizes business value and prepares Elixir for future client support. He also mentioned progress with the court-supervised process and the Rite Aid 2.0 Plan.
Press Release: Rite Aid Receives Court Approval for Sale of Elixir Solutions Business to MedImpactRite Aid was accused of recklessly implementing facial surveillance, leading to customer embarrassment and privacy threats. However, it rejected these allegations, claiming it was tied only to a terminated pilot project.
CNBC’s Jim Cramer outlined the ways that Federal Trade Commission chair Lina Khan has attempted to stop mergers and acquisitions from going through, hurting stock portfolios in the process.
“Khan’s FTC has deterred many a potential merger, and that’s kept stock valuations much lower than they should be as the Nippon Steel-U.S. Steel deal shows,” Cramer said Monday. “Yep, Khan’s been a one-woman wrecking crew for your stoc...
“Khan’s FTC has deterred many a potential merger, and that’s kept stock valuations much lower than they should be as the Nippon Steel-U.S. Steel deal shows,” Cramer said Monday. “Yep, Khan’s been a one-woman wrecking crew for your stoc...
7
Concerns rise as Rite Aid Corp's bankruptcy case may be harming low-ranking creditors by proceeding too quickly. Rite Aid stepping in with financing amid MedImpact's financial struggles in acquiring Rite Aid's pharmacy benefits manager could strain its resources.
Possible damage to corporate reputation and consumer trust in health product quality. Stricter rules and superior quality inspections might be needed, influencing operations and related expenses.
Read more